荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09995 荣昌生物

休市中 11-06 16:08:52

70.200

-1.100

-1.54%

最高72.150	最低67.550	成交量184.01万
今开67.850	昨收71.300	日振幅6.45%
总市值395.65亿	流通市值146.42亿	总股本5.64亿
成交额1.29亿	换手率0.88%	流通股本2.09亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"荣昌生物","latestPrice":70.2,"timestamp":1793952532009,"preClose":71.3,"halted":0,"volume":1840093,"delay":0,"changeRate":-0.015427769985974676,"floatShares":208581239,"shares":563608243,"eps":1.5160605727908656,"marketStatus":"休市中","change":-1.1,"latestTime":"11-06 16:08:52","open":67.85,"high":72.15,"low":67.55,"amount":129369148,"amplitude":0.064516,"askPrice":70.25,"askSize":2000,"bidPrice":70.15,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":13.63221452912576,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":7,"adr":0,"listingDate":1604851200000,"exchange":"SEHK","adjPreClose":71.3,"openAndCloseTimeList":[[1793928600000,1793937600000],[1793941200000,1793952000000]],"volumeRatio":0.6126182867836881,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"荣昌生物","latestPrice":95.2,"timestamp":1793948400000,"preClose":97.21,"halted":0,"volume":6329700,"delay":0,"premium":"-37.26"}},"requestUrl":"/m/hq/s/09995","defaultTab":"news","newsList":[{"id":"2681884019","title":"【券商聚焦】中信建投评26 ESMO：中国创新药持续突破，竞争与差异化并存","url":"https://stock-news.laohu8.com/highlight/detail?id=2681884019","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681884019?lang=zh_cn&edition=full","pubTime":"2026-11-06 08:57","pubTimestamp":1793926628,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，2026年欧洲内科肿瘤学会（European Society for Medical Oncology，ESMO）中，中国创新药在多瘤种领域全面发力，众多项目从早期探索迈入III期临床或BLA/NDA阶段。国内药企已在IO双抗及多抗、ADC、小分子靶向等赛道形成多线并进格局，III期阳性终点多点开花，持续产出具备国际竞争力的临床数据，标志着中国创新药研发不断从跟随创新迈向源头创新与全球引领的新阶段，行业发展逻辑从“fast-follow”迈入“first-in-class”与“best-in-class”并行的阶段。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1995351","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320764243.SGD","09688","LU0823426308.USD","LU0708995153.HKD","09926","09995","LU0315179316.USD","01801","02269","IE00BPRC5H50.USD","LU1188198961.HKD","01877","LU0455707207.USD","LU0228659784.USD","BK1574","LU1242518857.USD","LU2097828714.EUR","LU0128522744.USD","LU1960683339.HKD","06160","KCE","LU2242644610.SGD","LU1251922891.USD","LU2488822045.USD","BK1583","BK1191","06185","LU0348783233.USD","LU1226287529.USD","LU0516422952.EUR","LU0594300179.USD","LU1813983027.USD","LU0634319403.HKD","01177","KURE","LU1152091168.USD","LU1152091754.HKD","LU1242518931.SGD","LU1807302812.USD","01093","LU0417516571.SGD","LU0456827905.SGD","LU0540923850.HKD","LU0039217434.USD","02142","601066","BK1515","02616","LU0348766576.USD","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681079233","title":"荣昌生物（688331）披露2022年A股限制性股票激励计划B类权益预留授予第二个归属期符合归属条件公告，11月05日股价上涨1.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2681079233","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681079233?lang=zh_cn&edition=full","pubTime":"2026-11-05 22:07","pubTimestamp":1793887638,"startTime":"0","endTime":"0","summary":"截至2026年11月5日收盘，荣昌生物报收于97.21元，较前一交易日上涨1.62%，最新总市值为548.73亿元。公告显示，公司2022年A股限制性股票激励计划之B类权益预留授予第二个归属期归属条件已成就。本次拟归属限制性股票数量为18.022万股，来源为公司向激励对象定向发行A股普通股，授予价格36.36元/股。共有8名激励对象符合归属条件，其中包含1名董事、高级管理人员，其余为其他员工。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500042929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399300","03130","BK1574","688331","07233","09995","LU2328871848.SGD","LU2488822045.USD","82823","LU2148510915.USD","LU1969619763.USD","BK0239","82822","BK1147","159982","02843","BK1583","LU1064131003.USD","02822","BK1161","LU1064130708.USD","03188","83130","BK1610","83188","02823","82843","02827","82846","02846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140464624","title":"荣昌生物(09995)确认2022年股权激励B类预留股第二个归属期可归属18.022万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1140464624","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140464624?lang=zh_cn&edition=full","pubTime":"2026-11-05 21:20","pubTimestamp":1793884845,"startTime":"0","endTime":"0","summary":"荣昌生物制药（烟台）股份有限公司11月5日公告称，公司第三届董事会第七次会议审议通过了《关于公司2022年A股限制性股票激励计划之B类权益预留授予第二个归属期符合归属条件的议案》及《关于作废部分2022年A股限制性股票激励计划已授予尚未归属的限制性股票的议案》。根据法律意见书，本次归属及作废要点如下：","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158017260","title":"荣昌生物（09995）2022年限制性股票激励计划B类权益第二个归属期获委员会确认","url":"https://stock-news.laohu8.com/highlight/detail?id=1158017260","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158017260?lang=zh_cn&edition=full","pubTime":"2026-11-05 21:11","pubTimestamp":1793884268,"startTime":"0","endTime":"0","summary":"2026年11月5日，荣昌生物制药（烟台）股份有限公司在上海证券交易所网站发布公告称，其董事会薪酬与考核委员会已对公司2022年限制性股票激励计划中B类权益预留授予部分第二个归属期的归属名单完成核查。委员会确认，激励对象主体资格合法有效，且已满足本次激励计划设定的限制性股票归属条件。公告未披露具体归属股份数量或金额。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152808503","title":"荣昌生物预留限制性股票第二个归属期拟归属18.022万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1152808503","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152808503?lang=zh_cn&edition=full","pubTime":"2026-11-05 21:06","pubTimestamp":1793883977,"startTime":"0","endTime":"0","summary":"2026年11月5日，荣昌生物制药（烟台）股份有限公司公告称，其2022年A股限制性股票激励计划中B类权益预留授予第二个归属期已达到归属条件。董事会同意为符合条件的激励对象办理归属手续。本次可归属的限制性股票数量为18.022万股，授予价格为36.36元/股，占该类别已获授45.055万股的40%。本期共有8名激励对象符合归属条件，其中包括执行董事兼董事会秘书温庆凯，其可归属股份0.822万股；其余7名员工合计可归属17.200万股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122177690","title":"荣昌生物制药（09995）作废6.4万股 A 股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1122177690","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122177690?lang=zh_cn&edition=full","pubTime":"2026-11-05 21:05","pubTimestamp":1793883940,"startTime":"0","endTime":"0","summary":"2026年11月6日，荣昌生物制药（烟台）股份有限公司公告称，公司第三届董事会第七次会议已审议通过《关于作废部分2022年A股限制性股票激励计划已授予尚未归属的限制性股票的议案》，决定对已授予但尚未归属的6.4万股限制性股票予以作废。根据公告，公司确认上述作废事项不会对其经营情况、技术团队及管理团队稳定性产生重大影响，也不影响2022年A股限制性股票激励计划的继续实施。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123937507","title":"荣昌生物第三届董事会第七次会议通过两项股权激励相关议案","url":"https://stock-news.laohu8.com/highlight/detail?id=1123937507","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123937507?lang=zh_cn&edition=full","pubTime":"2026-11-05 21:01","pubTimestamp":1793883683,"startTime":"0","endTime":"0","summary":"2026年11月6日，荣昌生物制药（烟台）股份有限公司公告称，公司已于2026年11月5日召开第三届董事会第七次会议，9名董事全部出席，会议决议合法有效。\\n\\n会议审议并通过两项与2022年A股限制性股票激励计划相关的议案： \\n\\n1. 关于公司2022年A股限制性股票激励计划之B类权益预留授予第二个归属期符合归属条件的议案。董事会确认归属条件已成就，同意为符合条件的激励对象办理归属事项。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120285746","title":"荣昌生物（09995）披露第二次回购前股东持股结构：前十大股东合计持股约35%","url":"https://stock-news.laohu8.com/highlight/detail?id=1120285746","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120285746?lang=zh_cn&edition=full","pubTime":"2026-11-04 18:00","pubTimestamp":1793786452,"startTime":"0","endTime":"0","summary":"荣昌生物制药（烟台）股份有限公司11月5日公告称，公司已于2026年11月2日召开第三届董事会第六次会议，通过《2026年第二次以集中竞价交易方式回购公司股份方案》。该方案披露前一交易日登记在册的A股前十名股东及前十名无限售条件股东持股情况如下：","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111239414","title":"荣昌生物：贝莱德减持，好仓比例降至4.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=1111239414","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111239414?lang=zh_cn&edition=full","pubTime":"2026-11-04 17:33","pubTimestamp":1793784816,"startTime":"0","endTime":"0","summary":"贝莱德于2026年10月30日以场外方式卖出荣昌生物（09995）H股138.01万股，代价性质为非现金资产；该笔为场外交易，未经联交所公开市场撮合，不属二级市场直接买卖。贝莱德此次减持前持有荣昌生物好仓1059.61万，占比5.08%；减持后持股量为921.60万，好仓比例降至4.42%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680081628","title":"交银国际：维持荣昌生物(09995)“买入”评级 目标价调整至128港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680081628","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680081628?lang=zh_cn&edition=full","pubTime":"2026-11-04 14:20","pubTimestamp":1793773210,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，维持荣昌生物“买入”评级，大幅上调2026年对外许可收入预测，上调2026年、下调2027-28年收入预测，主要反映对外授权交易收入的最新确认节奏，以及基于1-3Q业绩对产品销售预测的调整。基于DCF模型调整目标价至128港元，隐含97%潜在涨幅，短期内丰富催化剂有望驱动估值修复。截至3Q26末，泰它西普和维迪西妥的商业化团队规模分别约900人/500人，年底至明年初将在泰它西普的肾科领域加大团队配置。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1518253.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EWH","688331","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680081626","title":"交银国际：维持荣昌生物(09995.HK)“买入”评级 目标价调整至128港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680081626","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680081626?lang=zh_cn&edition=full","pubTime":"2026-11-04 14:20","pubTimestamp":1793773210,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","LU2328871848.SGD","LU1969619763.USD","BK1574","09995","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118961689","title":"恒指午后走强涨超1%，创新药概念股强势拉升","url":"https://stock-news.laohu8.com/highlight/detail?id=1118961689","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118961689?lang=zh_cn&edition=full","pubTime":"2026-11-04 13:39","pubTimestamp":1793770784,"startTime":"0","endTime":"0","summary":"11月4日，恒指午后走强涨超1%，创新药概念股强势拉升，$药明生物(02269)$、$药明康德(02359)$涨超9%，$荣昌生物(09995)$、$百济神州(ONC)$涨超8%，$药明合联(02268)$涨超7%，$信达生物(01801)$、$康方生物(09926)$涨超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0052750758.USD","LU2097828557.USD","LU0543330566.HKD","MEDX","ONC","LU1251922891.USD","LU2488822045.USD","09926","LU1242518857.USD","LU0516422366.SGD","LU0051755006.USD","LU0029874905.USD","LU2242644610.SGD","LU1188198961.HKD","07200","02800","LU0043850808.USD","LU0417516902.SGD","02268","IE00B5MMRT66.SGD","BK1589","LU0828237510.HKD","LU2399975544.HKD","IE00BFMHRM44.USD","BK4585","LU0348784397.USD","02359","06160","513600","LU2476274308.USD","LU0501845795.SGD","LU0072913022.USD","LU0348825331.USD","LU1481107354.HKD","LU0140636845.USD","IE00BPRC5H50.USD","LU1961090484.USD","BK1521","LU0128522744.USD","LU0228659784.USD","03037","LU0605514214.HKD","LU1719994722.HKD","07300","LU0469268626.HKD","LU1880383366.USD","IE00B543WZ88.USD","LU0455707207.USD","MHImain","LU1720050803.USD","LU2045819591.USD","LU0320764243.SGD","LU2125910500.SGD","LU0594300419.USD","LU0149721374.USD","SG9999002463.SGD","07500","LU0039217434.USD","LU1831875114.USD","IE00B0JY6N72.USD","LU0979878070.USD","LU1046422090.SGD","BK1588","LU1770034418.SGD","LU0823426308.USD","LU2778985437.USD","LU1794554557.SGD","BK4139","LU0029874061.USD","LU0128526141.USD","LU0348735423.USD","LU1303224171.USD","LU2476274720.SGD","SG9999014674.SGD","LU2097828714.EUR","LU0561508036.HKD","LU0572944931.SGD","HSI","LU0516422440.USD","LU0516423091.SGD","LU2097828474.EUR","KURE","LU0456827905.SGD","LU0244354667.USD","09115","LU0348827113.USD","LU1969619763.USD","BK1574","LU2097828805.USD","LU0348783233.USD","03419","09995","SG9999002562.SGD","BK1610","LU0229945570.USD","01801","BK1576","LU0516423174.USD","LU0149534421.HKD","SG9999011746.SGD","BK4588","HK0000165453.HKD","82800","LU0359201612.USD","BK1500","LU0320764599.SGD","LU0359202008.SGD","LU0588546209.SGD","LU3063872942.SGD","LU0823426480.USD","LU0211977185.USD","MCHmain","LU1328277881.USD","LU1242518931.SGD","LU1688375341.USD","LU0516422952.EUR","LU0327786744.USD","LU2039709279.SGD","03115","LNGR","LU0348767384.USD","83115","LU0326950275.SGD","BK1583","LU0314109678.HKD","LU0594300179.USD","LU1813983027.USD","LU0856984785.SGD","LU0634319403.HKD","LU0650527681.SGD","LU0502904849.HKD","LU0164880469.USD","LU0417516738.SGD","02269","LU0607220059.USD","LU0708995583.HKD","06978","IBBQ","LU0348766576.USD","LU0540923850.HKD","LU0307460666.USD","LU0708995153.HKD","BK4526","BK1161","LU2328871848.SGD","LU0819121731.USD","02833","HHImain","HSImain","BK1141","159992","LU0181495838.USD","LU0417516571.SGD","LU0456846285.SGD","LU2097828631.EUR","LU0463099449.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680088400","title":"荣昌生物早盘涨逾6% 拟3000万元至6000万元回购公司A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680088400","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680088400?lang=zh_cn&edition=full","pubTime":"2026-11-04 11:38","pubTimestamp":1793763480,"startTime":"0","endTime":"0","summary":"模拟交易客户端荣昌生物早盘涨逾6%，截至发稿，股价上涨5.92%，现报66.25港元，成交额1.283亿港元。11月2日，荣昌生物发布公告，公司董事会审议通过《关于2026年第二次以集中竞价交易方式回购公司股份方案的议案》，拟使用公司自有资金和/或自筹资金通过集中竞价方式回购公司A股股份。回购的股份用于维护公司价值及股东权益。回购股份金额不低于3000万元（含），不超过6000万元（含），回购股份价格不超过131元/股（含）。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-11-04/doc-inixpvva1664009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["82822","BK1574","399300","02846","LU1969619763.USD","159982","BK1161","BK1610","02823","02827","02822","82843","BK1583","BK0239","82823","09995","03130","83188","LU2148510915.USD","LU2488822045.USD","LU2328871848.SGD","LU1064130708.USD","02843","03188","83130","82846","688331","LU1064131003.USD","BK1147","07233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110214194","title":"异动解读｜荣昌生物盘中上涨5.52%，拟3000万元至6000万元回购公司A股","url":"https://stock-news.laohu8.com/highlight/detail?id=1110214194","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110214194?lang=zh_cn&edition=full","pubTime":"2026-11-04 10:20","pubTimestamp":1793758846,"startTime":"0","endTime":"0","summary":"11月4日，荣昌生物盘中上涨5.52%，报66.0港元，成交额6519.47万港元。消息面上，公司日前公告拟使用3000万元至6000万元回购A股股份，回购价格上限为131元/股，用于维护公司价值及股东权益，对市场情绪形成提振。此次回购系年内第二次A股回购，触发背景为A股在10月27日前20个交易日累计跌幅超过20%。同时，公司此前首次回购截至10月31日已累计回购约6万股，耗资约663.2万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"荣昌生物异动上涨，回购计划提振信心","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680020457","title":"生物医药板块盘初走高 百济神州（06160）涨4.66%、药明生物（02269）涨3.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680020457","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680020457?lang=zh_cn&edition=full","pubTime":"2026-11-04 09:53","pubTimestamp":1793757224,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块盘初走高，截至发稿，百济神州 涨4.66%，药明生物涨3.99%，荣昌生物涨3.60%，药明康德涨3.52%，康方生物涨3.37%，再鼎医药涨2.43%，复宏汉霖涨2.37%，药明合联涨2.05%，泰格医药涨1.58%。华安证券研究指出，2026年三季度，医药板块跑赢大市、利润逐季加速。展望后市，该机构预计CXO、创新药、医疗器械与低基数修复。血制品、品牌中药三季度收入仍在下降。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1995176","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211977185.USD","LU0348827113.USD","LU0164880469.USD","LU0455707207.USD","BK4585","IE00BFMHRM44.USD","LU0417516738.SGD","LU2045819591.USD","688235","02359","LU2778985437.USD","BK1589","LU0516422440.USD","03347","09688","LU1794554557.SGD","LU0029874061.USD","LU0052750758.USD","SG9999002463.SGD","LU1969619763.USD","06160","LU0543330566.HKD","LU0823426480.USD","161726","LU1813983027.USD","LU0348767384.USD","LU0516422952.EUR","BK1588","LU0469268626.HKD","02268","09926","ONC","02269","LU0229945570.USD","399441","LU0456846285.SGD","XBI","LU0417516571.SGD","HK0000320223.HKD","LU0463099449.HKD","02696","KURE","LU0140636845.USD","IE00BPRC5H50.USD","LU0029874905.USD","BK0239","LU0540923850.HKD","09995","LU0979878070.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680270215","title":"港股异动 | 荣昌生物(09995.HK)涨超4% 拟3000万元至6000万元回购公司A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680270215","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680270215?lang=zh_cn&edition=full","pubTime":"2026-11-04 09:42","pubTimestamp":1793756566,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02846","02823","82846","83130","BK1583","07233","02822","09995","LU1969619763.USD","82843","BK1147","BK1610","02827","BK1574","BK1161","83188","82823","LU2328871848.SGD","03188","02843","03130","82822"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128695599","title":"港股生物医药股逆势上涨，百济神州涨超5%，药明生物、荣昌生物涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1128695599","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128695599?lang=zh_cn&edition=full","pubTime":"2026-11-04 09:36","pubTimestamp":1793756176,"startTime":"0","endTime":"0","summary":"11月4日，港股$生物(000504)$医药股逆势上涨，$百济神州(06160)$涨超5%，$药明生物(02269)$、$荣昌生物(09995)$涨超4%，$康方生物(09926)$、$复宏汉霖(02696)$、$药明康德(02359)$涨超3%。、","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688331","SG9999011746.SGD","IE00B5MMRT66.SGD","LU2399975544.HKD","HK0000306701.USD","BK0239","LU0140636845.USD","LU0828237510.HKD","LU0052750758.USD","LU2125910500.SGD","LU1328277881.USD","HK0000320223.HKD","LU2148510915.USD","LU1720050803.USD","LU2476274308.USD","BK4526","LU1813983027.USD","IE00BFMHRM44.USD","BK4139","09995","LU1688375341.USD","LU0348827113.USD","02269","LU0128526141.USD","LU0348735423.USD","LU0469268626.HKD","LU1719994722.HKD","LU1969619763.USD","LU1303224171.USD","LU0348783233.USD","LU0561508036.HKD","688235","LU0359201612.USD","HK0000320264.USD","LU0455707207.USD","BK4588","BK1574","LU0708995583.HKD","LU0348784397.USD","LU0856984785.SGD","SG9999002463.SGD","HK0000165453.HKD","LU0417516902.SGD","LU0228659784.USD","06160","09939","VXUS","LU2039709279.SGD","LU0320764599.SGD","LU2242644610.SGD","BK1500","LU0164880469.USD","BK1521","LU0543330566.HKD","BK1588","BK4581","HK0000306685.HKD","IE00BPRC5H50.USD","LU0320764243.SGD","LU0501845795.SGD","BK1583","LU0326950275.SGD","LU0516423091.SGD","SG9999002562.SGD","LU0348766576.USD","BK1141","XBI","IE00B543WZ88.USD","LU0348825331.USD","LU0708995153.HKD","LU0979878070.USD","LU1251922891.USD","399441","LU0516422440.USD","BK1589","LU2045819591.USD","LU3063872942.SGD","LU2476274720.SGD","LU0307460666.USD","LU0502904849.HKD","LU0029874061.USD","LU0516422952.EUR","LU1064130708.USD","LU1794554557.SGD","ONC","LU0823426480.USD","LU0456827905.SGD","02696","LU0819121731.USD","BK1610","LU0043850808.USD","09926","LU1064131003.USD","LU0128522744.USD","KURE","BK1576","02359","LU0417516571.SGD","LU0348767384.USD","LU2328871848.SGD","LU0516422366.SGD","LU1961090484.USD","BK4585","LU0051755006.USD","LU1770034418.SGD","LU1242518857.USD","LU0029874905.USD","LU0540923850.HKD","LU0823426308.USD","LU0314109678.HKD","LU0327786744.USD","LU0417516738.SGD","IE00B0JY6N72.USD","LU0211977185.USD","LU0456846285.SGD","LU2488822045.USD","KCAI","LU0149721374.USD","LU0572944931.SGD","LU0634319403.HKD","LU0229945570.USD","LU0072913022.USD","LU0588546209.SGD","161726","LU1242518931.SGD","LU1880383366.USD","LU1481107354.HKD","LU0039217434.USD","LU0359202008.SGD","LU2778985437.USD","LU0181495838.USD","LU0516423174.USD","BK1161","LU1046422090.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680701708","title":"荣昌生物（688331）11月3日主力资金净卖出4712.91万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680701708","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680701708?lang=zh_cn&edition=full","pubTime":"2026-11-04 08:50","pubTimestamp":1793753434,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月3日收盘，荣昌生物报收于84.9元，下跌8.93%，换手率2.87%，成交量10.23万手，成交额8.82亿元。近5日资金流向一览见下表：荣昌生物融资融券信息显示，融资方面，当日融资买入9610.03万元，融资偿还8285.6万元，融资净买入1324.43万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400011072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09995","LU1969619763.USD","LU2148510915.USD","LU1064131003.USD","LU2328871848.SGD","688331","BK1161","LU1064130708.USD","BK1574","BK0239","LU2488822045.USD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680947741","title":"贝莱德在荣昌生物的H股好仓比例上升0.05%至5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680947741","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680947741?lang=zh_cn&edition=full","pubTime":"2026-11-03 17:22","pubTimestamp":1793697720,"startTime":"0","endTime":"0","summary":"南财智讯11月3日电，香港交易所披露信息显示，BlackRock,Inc.（贝莱德）在荣昌生物的H股好仓（L）比例于10月29日从4.99%上升至5.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611033920341418.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611033920341418.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09995","LU1969619763.USD","LU2148510915.USD","LU1064131003.USD","LU2328871848.SGD","688331","BK1161","LU1064130708.USD","BK1574","BK0239","LU2488822045.USD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102897460","title":"荣昌生物10月股份变动月报表公布，股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1102897460","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102897460?lang=zh_cn&edition=full","pubTime":"2026-11-03 16:47","pubTimestamp":1793695668,"startTime":"0","endTime":"0","summary":"荣昌生物制药(烟台)股份有限公司于2026年11月3日披露2026年10月的股份变动月报表。公告显示，截至本月底公司法定/注册股本总额为人民币564,477,483元，其中H股和A股的注册股本分别为人民币208,581,239元和人民币355,896,244元，两类股份数量与上月相比均无变化。公司表示，截至10月31日，股本结构整体保持稳定，已满足香港联交所有关公众持股量的相关要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0825},{"period":"1month","weight":-0.0236},{"period":"3month","weight":-0.1861},{"period":"6month","weight":-0.2815},{"period":"1year","weight":-0.1922},{"period":"ytd","weight":-0.025}],"compareEarnings":[{"period":"1week","weight":0.051},{"period":"1month","weight":0.0146},{"period":"3month","weight":-0.0462},{"period":"6month","weight":-0.0724},{"period":"1year","weight":-0.0757},{"period":"ytd","weight":-0.0448}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"荣昌生物制药（烟台）股份有限公司是一家主要从事生物医药研究、生物医药服务及生物医药生产和销售的中国公司。该公司专注于抗体药物偶联物（ADC）、抗体融合蛋白、单抗及双抗等治疗性抗体药物领域。该公司的主要产品包括泰它西普、维迪西妥单抗、RC28-E等。该公司的产品主要应用于自身免疫疾病、肿瘤疾病、眼科疾病等重大疾病领域。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.110172},{"month":2,"riseRate":0.666667,"avgChangeRate":0.167223},{"month":3,"riseRate":0.5,"avgChangeRate":0.012545},{"month":4,"riseRate":0.833333,"avgChangeRate":0.095268},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.049233},{"month":6,"riseRate":0.666667,"avgChangeRate":0.089626},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.010221},{"month":8,"riseRate":0.333333,"avgChangeRate":0.055035},{"month":9,"riseRate":0.5,"avgChangeRate":0.07525},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.003277},{"month":11,"riseRate":1,"avgChangeRate":0.046039},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.053467}],"exchange":"SEHK","name":"荣昌生物","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荣昌生物,09995,荣昌生物股票,荣昌生物股票老虎,荣昌生物股票老虎国际,荣昌生物行情,荣昌生物股票行情,荣昌生物股价,荣昌生物股市,荣昌生物股票价格,荣昌生物股票交易,荣昌生物股票购买,荣昌生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}